Lumida
/XENE
⌘K
Xenon Pharmaceuticals Inc

Xenon Pharmaceuticals Inc

XENE
$60.72USD+0.93%+0.56 today

MARKET CAP

5.8B

P/E (TTM)

FWD P/E

DAY RANGE

$60 – $61

52W RANGE

$36
$73

AI Summary

Stalk
Sell NowMedium

Price has broken below key intermediate moving averages and exhibits short-term and medium-term bearish structure, despite an underlying long-term uptrend above the 200-day SMA. With no active bullish patterns and OS conditions yet not at extreme oversold levels, bearish momentum dominates, favoring sell-side engagement from intermediate resistance zones.

  • Cash, equivalents and securities of $1.2B fund operations through 2029.
  • Phase 3 X-TOLE2 highlights superior placebo-adjusted efficacy in focal seizures.
  • Q2 net loss grew to $110.7M from $84.7M YoY, intensifying cash burn.
Full analysis →
Insider Trades13 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Mar 13, 2026SellXENEAndrea DifabioChief Legal Officer1,342$55.22$5.8B-16.43%+70.56%$74.1K-6.75%10b5-1Stalk
Mar 13, 2026SellXENEChristopher John KenneyChief Medical Officer1,410$55.23$5.8B-16.43%+70.56%$77.9K-7.15%10b5-1Stalk
Mar 13, 2026SellXENEIan MortimerPRESIDENT & CEO7,308$55.23$5.8B-16.43%+70.56%$403.6K-11.29%10b5-1Stalk
Mar 10, 2026SellXENEAndrea DifabioChief Legal Officer2,607$60.11$5.8B-16.43%+70.56%$156.7K-17.38%10b5-1Stalk
Mar 10, 2026SellXENEChristopher John KenneyChief Medical Officer2,771$60.11$5.8B-16.43%+70.56%$166.6K-18.47%10b5-1Stalk
Mar 9, 2026SellXENEIan MortimerPRESIDENT & CEO551,269$34.08$5.8B-16.43%+70.56%$18.8M-2.05%10b5-1Stalk
Jan 2, 2026SellXENEIan MortimerPRESIDENT & CEO80,000$25.96$5.8B-16.43%+70.56%$2.1M+0.00%10b5-1Stalk
Dec 5, 2025SellXENEIan MortimerPRESIDENT & CEO25,205$45.33$5.8B-16.43%+70.56%$1.1M-44.97%10b5-1Stalk
Nov 28, 2025SellXENEIan MortimerPRESIDENT & CEO97$45.01$5.8B-16.43%+70.56%$4.4K-0.31%10b5-1Stalk
Oct 1, 2025SellXENEIan MortimerPRESIDENT, CEO & INTERIM CFO50,000$23.93$5.8B-16.43%+70.56%$1.2M+0.00%10b5-1Stalk
Jan 23, 2025SellXENEIan MortimerPRESIDENT & CEO110,000$29.01$5.8B-16.43%+70.56%$3.2M+0.00%10b5-1Stalk
Dec 18, 2024SellXENESherry AulinChief Financial Officer50,668$26.01$5.8B-16.43%+70.56%$1.3M+0.00%Stalk
Mar 7, 2024SellXENESherrington RobinEVP, Strategy & Innovation17,282$28.04$5.8B-16.43%+70.56%$484.5K+0.00%Stalk